Captopril effect on prostaglandin E2, thromboxane B2 and proteinuria in lupus nephritis patients
- 31 December 2005
- journal article
- research article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 78 (1-4), 194-201
- https://doi.org/10.1016/j.prostaglandins.2005.08.001
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The lupus paradox: Natural immunity is protective against diseaseKidney International, 2004
- An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritisKidney International, 2004
- Cyclooxygenases, the Kidney, and HypertensionHypertension, 2004
- Pharmacology and Cardiovascular Implications of the Kinin-Kallikrein SystemThe Japanese Journal of Pharmacology, 1999
- Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904Lupus, 1996
- Renal Function Changes in Microalbuminuric Normotensive Type II Diabetic Patients Treated With Angiotensin-Converting Enzyme InhibitorsDiabetes Care, 1993
- Morbidity of systemic lupus erythematosus: Role of race and socioeconomic statusAmerican Journal Of Medicine, 1991
- Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome.Annals Of The Rheumatic Diseases, 1990
- Improvement of Renal Function with Selective Thromboxane Antagonism in Lupus NephritisNew England Journal of Medicine, 1989
- Increased renal thromboxane production in murine lupus nephritis.Journal of Clinical Investigation, 1986